Previous 10 | Next 10 |
Prestige Consumer Healthcare Inc. (PBH) Q1 2023 Earnings Conference Call August 4, 2022, 8:30 AM ET Company Participants Phil Terpolilli - Vice President, Investor Relations and Treasurer Ron Lombardi - Chairman, President and CEO Christine Sacco - Chief Financia...
Prestige Consumer Healthcare press release ( NYSE: PBH ): FQ1 GAAP EPS of $1.09 beats by $0.05 . Revenue of $277.1M (+2.9% Y/Y) beats by $8.18M . FY2023 Outlook : Revenue: $1.12B to 1.13B vs. $1.12B consensus; Diluted EPS: $4.18 to $4.23 vs. $4.19...
Revenue of $277.1 Million in Q1 fiscal 2023 increased 2.9% versus Prior Year Diluted EPS of $1.09 for Q1, ahead of expectations Net Cash Provided by Operating Activities of $58.2 Million and Non-GAAP Free Cash Flow of $57.2 Million Reaffirming Full-Year Fiscal 2023 Revenue and...
TARRYTOWN, N.Y., July 11, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 first quarter earnings release on Thursday, August 4, 2022 before the opening of the market. The Company will host a conference call to discuss ...
The following slide deck was published by Prestige Consumer Healthcare Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Prestige Consumer Healthcare Inc. 2022 Q4 - Results - Earnings Call Presentation
A strong earnings result and a still attractive price to earnings ratio for Prestige Consumer Healthcare (NYSE:PBH) is prompting a more bullish view from Oppenheimer analyst Rupesh Parikh. The New York-based over-the-counter healthcare and household product distributor reported a beat on top ...
Prestige Consumer Healthcare Inc. (PBH) Q4 2022 Earnings Conference Call May 06, 2022 08:30 AM ET Company Participants Phil Terpolilli - VP, IR Ron Lombardi - Chairman, President and CEO Christine Sacco - CFO Conference Call Participants Rupesh Parikh - Oppenheimer Stephanie Wissink - Jefferi...
Prestige (NYSE:PBH) has reported easy beat on both lines in its fourth quarter earnings results with next year's guidance placed above the consensus mark. Revenue of $266.94M (+12.3% Y/Y) beats by $8.69M. That takes full-year revenue up 15.2% to $1.09B. By segment: North American OTC Hea...
Prestige Consumer Healthcare press release (NYSE:PBH): Q4 Non-GAAP EPS of $0.91 beats by $0.02. Revenue of $266.94M (+12.3% Y/Y) beats by $8.69M. Shares +8.5% AH. Outlook 2022 Revenue: $1.12B to 1.13B vs. $1.08B consensus. Diluted E.P.S.: $4.18 to $4.23 vs. $4.03 consensus. For further...
Company Exceeds Full-Year Earnings Outlook for Revenue, EPS, and Cash Flow Revenue of $266.9 Million in Q4 and $1,086.8 Million for Full-Year Fiscal 2022, up 12.3% and 15.2% versus Prior Year, respectively Adjusted Diluted EPS of $4.06 for Fiscal 2022, up 25.3% versus Prior Year ...
News, Short Squeeze, Breakout and More Instantly...
Prestige Consumer Healthcare Inc. Company Name:
PBH Stock Symbol:
NYSE Market:
Record Revenue of $289.3 Million in Q2 fiscal 2023 increased 4.7% versus Prior Year and 5.5% excluding Currency Diluted EPS of $1.02 for Q2, ahead of expectations Reduced Debt by $35 million in Q2 and Achieved Leverage Ratio of 3.7x Reaffirming Full-Year Fiscal 2023 Revenue an...
TARRYTOWN, N.Y., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2023 second quarter earnings release on Thursday, November 3, 2022 before the opening of the market. The Company will host a conference call to discu...
Presentation Times and Weblinks Released for Over 100 Presenting Companies Wednesday and Thursday, September 21-22, 2022 NEW YORK, NY / ACCESSWIRE / September 20, 2022 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day September Small-...